Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 20.833.529,57, with a 24-hour trading volume of Rp 24,11T. The asset's market cap is Rp 18,57P, after moving -1.05% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 20.884.813,11, with a tokenized market cap of Rp 814,64B and a 24-hour trading volume of Rp 34,69B. The tokenized asset has moved -0.27% in the past 24 hours.